EverSource Wealth Advisors
PRME icon

EverSource Wealth Advisors’s Prime Medicine PRME Stock Holding History

EverSource Wealth Advisors’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.08K Sell
1,376
-624
-31% -$2.07K ﹤0.01% 3272
2026
Q1 		$6.96K Buy
2,000
+238
+14% +$906 ﹤0.01% 3104
2025
Q4 		$6.11K Hold
1,762
– – ﹤0.01% 3039
2025
Q3 		$9.76K Buy
1,762
+400
+29% +$1.63K ﹤0.01% 2834
2025
Q2 		$3.36K Buy
1,362
+350
+35% +$540 ﹤0.01% 3313
2025
Q1 		$2.01K Buy
1,012
+1,006
+16,767% +$2.57K ﹤0.01% 2929
2024
Q4 		$18 Sell
6
-100
-94% -$351 ﹤0.01% 3715
2024
Q3 		$410 Hold
106
– – ﹤0.01% 2905
2024
Q2 		$595 Buy
+106
New +$643 ﹤0.01% 2852

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

EverSource Wealth Advisors's PRME Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Prime Medicine (PRME) stake by 31% in Q2 2026, selling an estimated $2.07K and leaving 1,376 shares worth $5.08K. The position accounts for ﹤0.01% of the portfolio, ranked #3272.

EverSource Wealth Advisors first reported a position in PRME in Q2 2024 and has held it in 9 quarters since. The position peaked at $9.76K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • EverSource Wealth Advisors held 1,376 shares of Prime Medicine worth $5.08K as of Q2 2026.
  • EverSource Wealth Advisors sold 624 Prime Medicine shares in Q2 2026, an estimated $2.07K.
  • Prime Medicine made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3272 holding.
  • EverSource Wealth Advisors first reported a position in Prime Medicine in Q2 2024 and has held it in 9 quarters since.
  • EverSource Wealth Advisors's Prime Medicine position peaked at $9.76K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.